| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 8, 2003
Accepted on January 27, 2004
signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway
Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, OH 45267
* To whom correspondence should be addressed. E-mail: nelson.horseman{at}uc.edu.
Both PRL (PRL) and transforming growth factor-
(TGF-) regulate cell survival in mammary epithelial cells, but their mechanisms of interactions are not known. In primary mammary epithelial cells and the HC11 mouse mammary epithelial cell line, PRL prevented TGF--induced apoptosis, as measured by terminal deoxynucleotidyltransferase dUTP nick-end labeling (TUNEL) staining and caspase-3 activation. This effect depended on phosphatidyl inositol triphosphate kinase (PI3K). PI3K activates a downstream serine/threonine kinase, Akt; therefore, we investigated the role of Akt in the interaction between PRL and TGF- signaling. Akt activity was inhibited by TGF- over a twenty to sixty minute time course. In TGF- treated cells, PRL disinhibited Akt in a PI3K-dependent manner. Expression of dominant negative Akt (DN-Akt) blocked the protective effect of PRL in TGF--induced apoptosis. Transgenic mice overexpressing a dominant-negative TGF- type II receptor in the mammary epithelium undergo hyperplastic alveolar development, and this effect was PRL-dependent. Involution in response to teat-sealing was slowed by overexpression of DNIIR; furthermore, Akt and forkhead phosphorylation increased in the sealed mammary glands of DNIIR mice. Thus, Akt appears to be an essential component of the interaction between PRL and TGF- signaling in mammary epithelial cells both in vitro and in vivo.
This article has been cited by other articles:
 |
|
 |
|
  N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cocolakis, M. Dai, L. Drevet, J. Ho, E. Haines, S. Ali, and J.-J. Lebrun Smad Signaling Antagonizes STAT5-mediated Gene Transcription and Mammary Epithelial Cell Differentiation J. Biol. Chem., January 18, 2008; 283(3): 1293 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sakamoto, B. A. Creamer, A. A. Triplett, and K.-U. Wagner The Janus Kinase 2 Is Required for Expression and Nuclear Accumulation of Cyclin D1 in Proliferating Mammary Epithelial Cells Mol. Endocrinol., August 1, 2007; 21(8): 1877 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Serra and M R Crowley Mouse models of transforming growth factor {beta} impact in breast development and cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 749 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Hogan and J. M. Stephens The Regulation of Fatty Acid Synthase by STAT5A Diabetes, July 1, 2005; 54(7): 1968 - 1975. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
